Toggle navigation
Home
Search
Services
Blog
Contact
About
Development and Toxicological Evaluation of Sustained-Re
Medisorb Technologies International, Lp, Cincinnati, OH, United States
Search grants from Medisorb Technologies International, Lp
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Center for Genome Interpretation
Technology-based adaptive treatment strategies for antiretroviral adherence
Childhood Obesity Treatment - A Maintenance Approach
RNA Catalyzed Splicing and Nucleotide Polymerization
Clbp: Biobehavioral Factors in Maintenance & Treatment
Recently added grants:
The role of the posterior cingulate cortex in mindfulness-based pain relief
Treatment and Prevention of Systemic Candidiasis
Redirected T Cell Therapy to Cure Invasive Fungal Infections
The role of NF-kappaB signaling in breast cancer metastasis
Efficacy and Mechanisms of Mild Therapeutic Hypothermia for Hearing Preservation from NIHL
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA029209-000
Application #
2306221
Study Section
Project Start
1992-09-30
Project End
Budget Start
1992-09-30
Budget End
1993-06-15
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Medisorb Technologies International, Lp
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45242
Related projects
NIH 1994
N01 DA
Development and Toxicological Evaluation
Atkins, Thomas J. / Medisorb Technologies International, Lp
NIH 1993
N01 DA
Development and Toxicological Evaluation of Sustained-Re
Atkins, Tom / Medisorb Technologies International, Lp
NIH 1993
N01 DA
Development and Toxicological Evaluation
Atkins, Thomas J. / Medisorb Technologies International, Lp
NIH 1992
N01 DA
Development and Toxicological Evaluation of Sustained-Re
/ Medisorb Technologies International, Lp
Comments
Be the first to comment on this grant